Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2011-Investor-Update/default.aspx
Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2011-Investor-Update/default.aspx
Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-to-Present-at-Credit-Suisse-2011-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-to-Present-at-Credit-Suisse-2011-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2011-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2011-Investor-Update-Call/default.aspx
Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-and-Forest-to-Present-Linaclotide-Results-from-Phase-2B-and-Phase-3-Trials-in-Patients-with-Irritable-Bowel-Syndrome-with-Constipation-or-Chronic-Constipation/default.aspx
Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-and-Forest-to-Present-Linaclotide-Results-from-Phase-2B-and-Phase-3-Trials-in-Patients-with-Irritable-Bowel-Syndrome-with-Constipation-or-Chronic-Constipation/default.aspx
Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-and-Forest-Announce-Linaclotide-New-Drug-Application-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation-and-Chronic-Constipation-Accepted-for-FDA-Review/default.aspx
Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review
https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-and-Forest-Announce-Linaclotide-New-Drug-Application-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation-and-Chronic-Constipation-Accepted-for-FDA-Review/default.aspx